Nitric oxide detection by DAF (diaminofluorescein) fluorescence in human myometrial tissue

Gynecological Endocrinology

Volumn 24, Issue 6, 2008, Pages 306-311

  Schwendemann, Julia ^a   Sehringer, Bernd ^a   Noethling, Claudia ^a   Zahradnik, Hans Peter ^a   Schaefer, Wolfgang R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

4,5 diaminofluorescein 2 diacetate; Myometrium; Nitric oxide; Nitric oxide synthase; Pregnancy

Indexed keywords

4,5 DIAMINOFLUORESCEIN 2 DIACETATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; GLUTARALDEHYDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CESAREAN SECTION; EXPLANT; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABOR; MYOMETRIUM; PILOT STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; TISSUE FIXATION; UTERUS CONTRACTILITY;

FEMALE; FLUORESCEIN; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MICROSCOPY, FLUORESCENCE; MYOMETRIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PILOT PROJECTS; PREGNANCY;

EID: 46349090649     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590801994063     Document Type: Article

References (25)

1. Knowles RG, Moncada S. Nitric-oxide synthases in mammals. Biochem J 1994;298:249-258.
2. Chwalisz K, Garfield RE. Role of nitric oxide in the uterus and cervix: implications for the management of labor. J Perinat Med 1998;26:448-457.
3. Garfield RE, Saade G, Buhimschi C, Buhimschi I, Shi L, Shi SQ, Chwalisz K. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update 1998;4:673-695.
4. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des 2003;9:359-380.
5. Norman JE, Thomson AJ, Telfer JF, Young A, Greer IA, Cameron IT. Myometrial constitutive nitric oxide synthase expression is increased during human pregnancy. Mol Hum Reprod 1999;5:175-181.
6. Ledingham MA, Thomson AJ, Greer IA, Norman JE. Nitric oxide in parturition. Br J Obstet Gynaecol 2000;107:581-593.
7. Buxton ILO. Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol Pharmacol 2004;65:1051-1059.
8. Al-Hijji J, Andolf E, Laurini R, Bauer J. Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium. Reprod Biol Endocrinol 2003;1:51.
9. Wetzka B, Stehmans A, Schäfer WR, Zahradnik HP. Effects of nitric oxide donors on the contractility and the prostaglandin synthesis of myometrial strips from pregnant and nonpregnant women. Gynecol Endocrinol 2001;15:34-42.
10. Bartlett SR, Bennett PR, Campa JS, Dennes WJ, Slater DM, Mann GE, Poston L, Poston R. Expression of nitric oxide synthase isoforms in pregnant human myometrium. J Physiol 1999;521:705-716.
11. Hertelendy F, Zakar T. Prostaglandins and the myometrium and cervix. Prostaglandins Leukot Essent Fatty Acids 2004;70:207-222.
12. Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2002;(3):CD002860.
13. Bisitis A, Madsen G, Knox M, Gill A, Smith R, Yeo G, Kwek K, Daniel M, Leung TN, Cheung K, et al. The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor. Am J Obstet Gynecol 2004;191:683-690.
14. Telfer JF, Lyall F, Norman JE, Cameron IT. Identification of nitric oxide synthase in human uterus. Hum Reprod 1995;10:19-23.
15. Favini R, Aldieri E, Revelli A, Bosia A, Massobrio M, Ghigo D. Nitric oxide synthesis in human nonpregnant myometrium and uterine myomas. Fertil Steril 2003;79(Suppl 1):749-753.
16. Kojima H, Sakurai K, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem Pharm Bull 1998;46:373-375.
17. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 1998;70:2446-2453.
18. Takumida M, Anniko M. Detection of nitric oxide in the guinea pig inner ear, using a combination of aldehyde fixative and 4,5-diaminofluorescin diacetate. Acta Otolaryngol 2001;121:460-464.
19. Kono T, Chisato N, Ebisawa Y, Asama T, Sugawara M, Ayabe T, Kohgo Y, Kasai S, Yoneda M, Takahashi T. Impaired nitric oxide production of the myenteric plexus in colitis detected by a new bioimaging system. J Surg Res 2004;117:329-338.
20. Lopez-Figueroa MO, Caamano C, Marin R, Guerra B, Alonso R, Morano I, Akil H, Watson SJ. Characterization of basal nitric oxide production in living cells. Biochim Biophys Acta 2001;1540:253-264.
21. Broillet MC, Randin O, Chatton JY. Photoactivation and calcium sensitivity of the fluorescent NO indicator 4,5-diaminofluorescein (DAF-2): implications for cellular NO imaging. FEBS Lett 2001;491:227-232.
22. Suzuki N, Kojima H, Urano Y, Kikuchi K, Hirata Y, Nagano T. Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO. J Biol Chem 2002;277:47-49.
23. Carvalho FA, Martins-Silva J, Saldanha C. Amperometric measurements of nitric oxide in erythrocytes. Biosens Bioelectron 2004;20:505-508.
24. Aggelidou E, Hillhouse EW, Grammatopoulos DK. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA 2002;99:3300-3305.
25. Kakui K, Itoh H, Sagawa N, Yura S, Korita D, Takemura M, Miyamaoto Y, Saito Y, Nakao K, Fujii S. Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)α and ERβ. Mol Hum Reprod 2004;10:115-122.